Follicular and Hurthle Cell Carcinoma: Comparison of Clinicopathological Features and Clinical Outcomes-Reference-Cited by-同舟云学术

Follicular and Hurthle Cell Carcinoma: Comparison of Clinicopathological Features and Clinical Outcomes

Published:2022-03-01 Issue:3 Volume:32 Page:245-254
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Matsuura Danielli¹^ORCID,Yuan Avery¹,Wang Laura¹,Ranganath Rohit¹,Adilbay Dauren¹,Harries Victoria¹,Patel Snehal¹,Tuttle Michael²,Xu Bin³^ORCID,Ghossein Ronald³,Ganly Ian¹

Affiliation:

1. Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

2. Endocrinology Service, Department of Medicine, Memorial Hospital for Cancer and Allied Diseases, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

3. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2021.0424

Reference30 articles.

1. Follicular Thyroid Cancer Incidence Patterns in the United States, 1980–2009

2. Hürthle cell carcinoma: A 60-year experience

3. Follicular and Hörthle Cell Carcinoma of the Thyroid

4. 4. Lloyd RV, Osamura RY, Klöppel G, Rosai J; World Health Organization; International Agency for Research on Cancer 2017 WHO Classification of Tumours of Endocrine Organs. Vol 10. Fourth edition. IARC Publications, Lyon.

5. Short Review: Genomic Alterations in Hürthle Cell Carcinoma

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of prognosis between oncocytic thyroid carcinoma and follicular thyroid carcinoma: a population-based propensity score matching analysis;European Archives of Oto-Rhino-Laryngology;2024-09-11

2. Impact of Reclassification of Oncocytic and Follicular Thyroid Carcinoma by the 2022 WHO Classification;The Journal of Clinical Endocrinology & Metabolism;2024-08-21

3. Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part I. Initial Management of Differentiated Thyroid Cancers - Chapter 5. Evaluation of Recurrence Risk Postoperatively and Initial Risk Stratification in Differentiated Thyroid Cancer 2024;International Journal of Thyroidology;2024-05-30

4. Clinical Outcomes and Implications of Radioactive Iodine Therapy on Cancer-specific Survival in WHO Classification of FTC;The Journal of Clinical Endocrinology & Metabolism;2024-03-04

5. Molecular Alterations and Comprehensive Clinical Management of Oncocytic Thyroid Carcinoma;JAMA Otolaryngology–Head & Neck Surgery;2024-03-01